ADHD: Clinical Trials

1 trial for ADHD, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 enrolling by invitation. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Enrolling by invitation 1

Follow ADHD: new trials by email Literature Review of ADHD trials Research Report on ADHD

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
An Open-Label Study to Assess the Long-Term Safety of Solriamfetol in Children and Adolescents With ADHD
Solriamfetol - ADHD
Phase 3Enrolling by invitationAxsome Therapeutics, Inc.3002026-08-062026-10-13

Narrower conditions

Attention Deficit Disorder with Hyperactivity (1)

Broader conditions

Attention Deficit and Disruptive Behavior Disorders (1)  ·  Mental Disorders (1)  ·  Neurodevelopmental Disorders (1)

Interventions

solriamfetol (1)

Sponsors

Axsome Therapeutics, Inc. (1)

Countries

United States (1)